Per Hydbring
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Oncology top 2%
- Cancer-related Molecular Pathways
Papers in
-
- MicroRNA in disease regulation 8
- Oncology 13
- Cancer-related Molecular Pathways 9
- Lung Cancer Research Studies 3
- Co-authors
- Lars‐Gunnar Larsson (9 shared papers)Ola Söderberg (3 shared papers)Fuad Bahram (4 shared papers)Karin Ridderstråle (2 shared papers)Piotr Siciński (4 shared papers)Mats T. Gullberg (1 shared paper)Malin Jarvius (1 shared paper)Kenneth Wester (1 shared paper)
- Journals
- Translational Lung Cancer Research (9 papers)Cancer Cell (3 papers)F1000Research (3 papers)Lung Cancer (2 papers)Nature Cell Biology (2 papers)
- Partner nations
- SwedenUnited StatesChina
In The Last Decade
Per Hydbring
45 papers receiving 5.7k citations
Per Hydbring's Hit Papers
Peers
Comparison fields: 5 of 103
- Cancer Research 684
- Oncology 964
- Geriatrics and Gerontology 144
- Molecular Biology 2.5k
- Cell Biology 396
Countries citing papers authored by Per Hydbring
This map shows the geographic impact of Per Hydbring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Hydbring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Hydbring more than expected).
Fields of papers citing papers by Per Hydbring
This network shows the impact of papers produced by Per Hydbring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Hydbring. The network helps show where Per Hydbring may publish in the future.
Co-authors
The 25 scholars most cited alongside Per Hydbring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Direct observation of individual endogenous protein complexes in situ by proximity ligation Hit paper breakdown → | 2006 | 2044 |
| 2 | A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer Cells Hit paper breakdown → | 2011 | 467 |
| 3 | 2016 | 416 | |
| 4 | 2003 | 410 | |
| 5 | 2005 | 395 | |
| 6 | 2012 | 292 | |
| 7 | 2011 | 234 | |
| 8 | 2009 | 216 | |
| 9 | 2009 | 171 | |
| 10 | 2017 | 138 | |
| 11 | 2013 | 121 | |
| 12 | 2013 | 117 | |
| 13 | 2018 | 108 | |
| 14 | 2017 | 87 | |
| 15 | 2017 | 72 | |
| 16 | 2018 | 61 | |
| 17 | 2010 | 57 | |
| 18 | 2017 | 50 | |
| 19 | 2010 | 36 | |
| 20 | 2019 | 25 |
About Per Hydbring
Per Hydbring is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Physiology and Molecular Biology, having authored 47 papers that have together received 5.8k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (9 papers), Lung Cancer Treatments and Mutations (8 papers), MicroRNA in disease regulation (8 papers), Telomeres, Telomerase, and Senescence (7 papers), Lung Cancer Research Studies (3 papers), Ubiquitin and proteasome pathways (2 papers), Brain Metastases and Treatment (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Cancer Research (684 citations), Oncology (964 citations), Geriatrics and Gerontology (144 citations), Molecular Biology (2.5k citations) and Cell Biology (396 citations). Per Hydbring has collaborated with scholars based in Sweden, United States and China. Frequent co-authors include Lars‐Gunnar Larsson, Ola Söderberg, Fuad Bahram, Karin Ridderstråle, Piotr Siciński, Mats T. Gullberg, Malin Jarvius, Kenneth Wester, Karl‐Johan Leuchowius and Ulf D. Landegren. Their work appears in journals such as Translational Lung Cancer Research, Cancer Cell, F1000Research, Lung Cancer and Nature Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.